Back to Search Start Over

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis

Authors :
Juergen Braun
Wilson Bautista-Molano
Nurullah Akkoc
Helena Marzo-Ortega
Fernando Pimentel Dos Santos
Filip Van den Bosch
M. Tuncay Duruoz
Bassel Elzorkany
Désirée van der Heijde
Simeon Grazio
Uta Kiltz
Victoria Navarro-Compán
Tae-Jong Kim
Jieruo Gu
Ruben Burgos-Vargas
Simon Stebbings
James Cheng-Chung Wei
Astrid van Tubergen
Praveena Chiowchanwisawakit
Annelies Boonen
Robert D. Inman
Maxime Dougados
Inna Gaydukova
Salih Ozgocmen
Michele Gilio
Lianne S. Gensler
Michael Schirmer
Kiltz, Uta
van der Heijde, Desiree
Boonen, Annelies
Akkoc, Nurullah
Bautista-Molano, Wilson
Burgos-Vargas, Ruben
Wei, James Cheng-Chung
Chiowchanwisawakit, Praveena
Dougados, Maxime
Duruoz, M. Tuncay
Elzorkany, Bassel Kamal
Gaydukova, Inna
Gensler, Lianne S.
Gilio, Michele
Grazio, Simeon
Gu, Jieruo
Inman, Robert D.
Kim, Tae-Jong
Navarro-Compan, Victoria
Marzo-Ortega, Helena
Ozgocmen, Salih
dos Santos, Fernando Pimentel
Schirmer, Michael
Stebbings, Simon
van den Bosch, Filip E.
van Tubergen, Astrid
Braun, Juergen
RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation
Interne Geneeskunde
MUMC+: MA Reumatologie (9)
Source :
Annals of the Rheumatic Diseases, 77(9), 1311-1317. BMJ Publishing Group, Annals of the Rheumatic Diseases, 77(9), 1311-1317
Publication Year :
2018

Abstract

ObjectivesTo evaluate construct validity, interpretability, reliability and responsiveness as well as determination of cut-off points for good and poor health within the original English version and the 18 translations of the disease-specific Assessment of Spondyloarthritis international Society Health Index (ASAS HI) in 23 countries worldwide in patients with spondyloarthritis (SpA).MethodsA representative sample of patients with SpA fulfilling the ASAS classification criteria for axial (axSpA) or peripheral SpA was used. The construct validity of the ASAS HI was tested using Spearman correlation with several standard health outcomes for axSpA. Test–retest reliability was assessed by intraclass correlation coefficients (ICCs) in patients with stable disease (interval 4–7 days). In patients who required an escalation of therapy because of high disease activity, responsiveness was tested after 2–24weeks using standardised response mean (SRM).ResultsAmong the 1548 patients, 64.9% were men, with a mean (SD) age 42.0 (13.4) years. Construct validity ranged from low (age: 0.10) to high (Bath AnkylosingSpondylitisFunctioning Index: 0.71). Internal consistency was high (Cronbach’s α of 0.93). The reliability among 578 patients was good (ICC=0.87 (95% CI 0.84 to 0.89)). Responsiveness among 246 patients was moderate-large (SRM=−0.44 for non-steroidal anti-inflammatory drugs, −0.69 for conventional synthetic disease-modifying antirheumatic drug and −0.85 for tumour necrosis factor inhibitor). The smallest detectable change was 3.0. Values ≤5.0 have balanced specificity to distinguish good health as opposed to moderate health, and values ≥12.0 are specific to represent poor health as opposed to moderate health.ConclusionsThe ASAS HI proved to be valid, reliable and responsive. It can be used to evaluate the impact of SpA and its treatment on functioning and health. Furthermore, comparison of disease impact between populations is possible.

Details

Language :
English
ISSN :
00034967
Volume :
77
Issue :
9
Database :
OpenAIRE
Journal :
Annals of the Rheumatic Diseases
Accession number :
edsair.doi.dedup.....e0ae442b58f0401d7cd34e6de7f19040
Full Text :
https://doi.org/10.1136/annrheumdis-2017-212076